ID
11733
Beschreibung
The primary objective of this clinical trial is to evaluate safety of switching from fondaparinux to either unfractionated heparin or bivalirudin for patients experiencing acute coronary syndrome undergoing percutaneous coronary angioplasty.
Stichworte
Versionen (2)
- 28.07.15 28.07.15 -
- 21.11.15 21.11.15 -
Hochgeladen am
28. Juli 2015
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0 Legacy
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Criteria: Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI (SWITCHIII)
Eligibility Criteria
- StudyEvent: ODM
Beschreibung
Exclusion criteria
Beschreibung
ST elevated myocardial infarction within the preceding 48 hours
Datentyp
boolean
Alias
- UMLS CUI-1
- C1536220
Beschreibung
Patient weighs more than 400 lbs (181.2 kg) or less than 110 lbs (50 kg)
Datentyp
boolean
Alias
- UMLS CUI-1
- C0005910
Beschreibung
Patients presenting on or received bivalirudin within the preceding 24 hours;
Datentyp
boolean
Alias
- UMLS CUI-1
- C0168273
Beschreibung
Patients presenting on or received GP IIb/IIIa inhibitors within the preceding 24 hours;
Datentyp
boolean
Alias
- UMLS CUI-1
- C3640054
Beschreibung
Patients presenting on or received low-molecular weight heparin within the preceding 24 hours
Datentyp
boolean
Alias
- UMLS CUI-1
- C3536766
Beschreibung
Patients that received unfractionated heparin less than or equal to 90 minutes prior to fondaparinux administration.
Datentyp
boolean
Alias
- UMLS CUI-1
- C2825026
Beschreibung
Patients with known conditions of bleeding diathesis
Datentyp
boolean
Alias
- UMLS CUI-1
- C3251812
Beschreibung
Patients with actively bleeding within the previous 6 months (GI bleed etc.);
Datentyp
boolean
Alias
- UMLS CUI-1
- C0019080
Beschreibung
Known diagnosis of acute bacterial endocarditis;
Datentyp
boolean
Alias
- UMLS CUI-1
- C0014121
Beschreibung
Patients with cardiogenic shock
Datentyp
boolean
Alias
- UMLS CUI-1
- C0036980
Beschreibung
Required intra-aortic balloon pump (IABP)
Datentyp
boolean
Alias
- UMLS CUI-1
- C0021860
Beschreibung
If patient is on warfarin (Coumadin) therapy
Datentyp
boolean
Alias
- UMLS CUI-1
- C0043031
Beschreibung
Patients who had a major or minor stroke (CVA or TIA)
Datentyp
boolean
Alias
- UMLS CUI-1
- C0559159
Beschreibung
Patients who had a major surgery within the past 6 months;
Datentyp
boolean
Alias
- UMLS CUI-1
- C0679637
Beschreibung
Known impaired renal function (creatinine ≥ 3.0 mg/dL (265.2 μmol/L)
Datentyp
boolean
Alias
- UMLS CUI-1
- C0035078
Beschreibung
status post renal transplant
Datentyp
boolean
Alias
- UMLS CUI-1
- C0022671
Beschreibung
patients on chronic dialysis
Datentyp
boolean
Alias
- UMLS CUI-1
- C0019004
Beschreibung
creatinine clearance ≤ 30 ml/min
Datentyp
boolean
Alias
- UMLS CUI-1
- C0373595
Beschreibung
A platelet count of less than 100,000 cells/mm3;
Datentyp
boolean
Alias
- UMLS CUI-1
- C0032181
Beschreibung
Known allergies to fondaparinux, aspirin, clopidogrel bisulfate (PlavixR), ticlopidine (TiclidR), heparin, bivalirudin, that cannot be medically managed;
Datentyp
boolean
Alias
- UMLS CUI-1
- C0013182
Beschreibung
Known allergies to contrast that cannot be medically managed;
Datentyp
boolean
Alias
- UMLS CUI-1
- C0570562
Beschreibung
Prior angioplasty within the previous 30 days;
Datentyp
boolean
Alias
- UMLS CUI-1
- C3532648
Beschreibung
Contraindication to low-molecular weight heparin
Datentyp
boolean
Alias
- UMLS CUI-1
- C3536766
- UMLS CUI-2
- C0522473
- UMLS CUI-3
- P
Beschreibung
Contraindication to unfractionated heparin
Datentyp
boolean
Alias
- UMLS CUI-1
- C2825026
- UMLS CUI-2
- C0522473
- UMLS CUI-3
- P
Beschreibung
Contraindication to bivalirudin;
Datentyp
boolean
Alias
- UMLS CUI-1
- C0168273
- UMLS CUI-2
- C0522473
- UMLS CUI-3
- P
Beschreibung
Pregnant or lactating women;
Datentyp
boolean
Alias
- UMLS CUI-1
- C0549206
Beschreibung
Pregnant or lactating women;
Datentyp
boolean
Alias
- UMLS CUI-1
- C2828358
Beschreibung
Currently participating in an investigational drug or another device study.
Datentyp
boolean
Alias
- UMLS CUI-1
- C0422740
Ähnliche Modelle
Eligibility Criteria
- StudyEvent: ODM
C0522473 (UMLS CUI-2)
P (UMLS CUI-3)
C0522473 (UMLS CUI-2)
P (UMLS CUI-3)
C0522473 (UMLS CUI-2)
P (UMLS CUI-3)